| 000 | 01662 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517181144.0 | ||
| 264 | 0 | _c20180706 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc-2017-0120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAtta, Kamal Fahmy Mohamed | |
| 245 | 0 | 0 |
_aSynthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _c10 2017 |
||
| 300 |
_a1913-1929 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmphotericin B _xpharmacology |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aDeoxycholic Acid _xpharmacology |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmania major _xdrug effects |
| 650 | 0 | 4 |
_aMolecular Docking Simulation _xmethods |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPhosphorylcholine _xanalogs & derivatives |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPyrazoles _xchemistry |
| 650 | 0 | 4 |
_aPyrimidines _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aIbrahim, Tamer Mohamed | |
| 700 | 1 | _aFarahat, Omaima Osman Mahmoud | |
| 700 | 1 | _aAl-Shargabi, Tareq Qasem | |
| 700 | 1 | _aMarei, Mohamed Gaber | |
| 700 | 1 | _aBekhit, Adnan Ahmed | |
| 700 | 1 | _aEl Ashry, El Sayed Helmy | |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 9 _gno. 16 _gp. 1913-1929 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc-2017-0120 _zAvailable from publisher's website |
| 999 |
_c27681156 _d27681156 |
||